A Clinical Study of NAD in the Treatment of Immune Thrombocytopenia

Clinical trial NCT06776510 · RECRUITING

Trial details

NCT number: NCT06776510
Sponsor: Institute of Hematology & Blood Diseases Hospital, China
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Immune Thrombocytopenia Treatment

Start date: 2025-01-15
Primary completion: 2025-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.